more complex than the acronym suggests, with other systems potentially involved including the immune system. Mutations in the chromodomain helicase DNA-binding 7 (CHD7) gene have been identified in up to 90% of patients with CHARGE syndrome (Bergman et al., 2011; Janssen et al., 2012) . CHD7 is essential for multi-potent neural crest cell migration, which differentiates into a variety of tissues, including neural, cardiac, genitourinary, craniofacial, and thymic/parathyroid structures. Immunodeficiency in individuals with CHARGE syndrome is not unexpected given the potential for thymic maldevelopment; however, its prevalence and severity remain poorly defined because of a general lack of published systemic assessment from large CHARGE cohorts. Most reports are of single case descriptions or retrospective series, invariably resulting in a publication bias of more severe phenotypes. However the severity of immunodeficiency in CHARGE syndrome can vary from asymptomatic derangements in absolute T-cells to life threatening severe combined immunodeficiency (SCID), also termed complete Di George anomaly.
This review summarizes the immune defects reported in CHARGE, compares the immune defects in CHARGE with those reported in 22q11.2 deletion syndrome and discusses future research priorities.
| THE IMMUNE SYSTEM IN CHARGE SYNDROME
The immune system has two broad divisions, the innate and adaptive arms. The first line of defense against invading pathogens is the innate system which does not rely on specific antigen/allergen recognition or memory responses and includes functions of cells such as neutrophils, macrophages, and natural killer (NK) cells and of a group of proteins such as complement, toll like protein receptors and other pathogen pattern recognition receptors. To date, no defects in this system have been reported in those with CHARGE syndrome. The adaptive arm principally comprises of T-cells (CD4 and CD8 cells) and B-cells. T-cells are essential in initiating, coordinating and then dampening the adaptive immune response to pathogens. They assist B-cells in producing immunoglobulins essential for the pathogen removal. The thymus is essential for T-cell maturation, self and non-self-programming and T cell regulation. In essence it is where T cells are educated after they are produced in the bone marrow.
Immunodeficiency in CHARGE syndrome is rare, and occurs largely due to impairment in thymic development, and thus functional T-cell production. The severity of the immunodeficiency relates to the degree of thymic maldevelopment. Complete thymic aplasia, although very rare, results in a severe immunodeficiency with complete/near complete absence of T-cells and abnormal B-cell function with associated hypogammaglobulinaemia. Without effective immune reconstitution these children will die from infection.
Partial thymic aplasia may result in no detectable defect at all, mild reduction in T-cells with no clinical consequence, or more significant reduction in T-cells with associated B-cell function impairment, resulting in recurrent infections which will require prophylactic antibiotics and/or immunoglobulin infusions but not immune reconstitution. Pure B-cell or antibody defects are rarely described in CHARGE syndrome.
| Presentations with infections
The vast majority of children with CHARGE syndrome do not appear to have an immune defect on functional in vitro immune assessment, yet, have a propensity for chest and ear infections. This is primarily due to underlying anatomical and functional abnormalities, with increased risks of aspiration from bulbar dysfunction and altered eustachian tube anatomy. In the combined published paediatric cohorts of Hsu et al. (2016) and , no child had a significant immune defect, yet two thirds of cases had a prior history of otitis media (often requiring tympanostomy tubes) and one quarter had pneumonia. Although other invasive infections were not documented, both cohorts typically included older children presenting to specialized outpatient clinics. Recurrent suppurative sinopulmonary or lifethreatening infections, however, have been reported in cases of CHARGE with concurrent immunodeficiency (reviewed in .
| Partial thymic hypoplasia
There is no universally accepted definition for partial thymic hypoplasia. In conditions such as CHARGE and 22q11.2 deletion syndromes where thymic hypoplasia is reported, reduced or naïve CD4/CD8 cell counts are used as surrogate markers for a small thymus. Partial thymic hypoplasia may result in lymphopenia, reduced CD3 counts, and/or reduced CD4 or CD8 counts.
| Lymphopenia
The two studies of Hsu et al. (2016) and are the only published prospective studies that have reported detailed immune-phenotypes in children with CHARGE syndrome. Of the combined cohort of 44 children, none were lymphopenic at the time of evaluation (in four cases, CD3 counts were only mildly reduced). In contrast, Jyonouchi et al. (2009) reported that in their retrospective study, 15 out of 25 children with CHARGE syndrome (60%) were lymphopenic, despite using the same reference ranges as Hsu et al. (2016) and . Nine patients had T-cell enumeration, with four having very low CD3 cells (two of whom had a complete Di George anomaly). The differences between the studies likely relates to the populations studied, with Hsu et al. (2016) and predominately studying older children attending specialized outpatient clinics over a short period of time, while Jyonouchi, McDonald-McGinn, Bale, Zackai, and Sullivan (2009) included much younger infants attending a tertiary hospital over 10 years.
When Hsu et al. (2016) evaluated lymphocyte counts in children with CHARGE who had a full blood count within the first 72 months of life, they found 4 out of the 14 patients evaluated (30%) were lymphopenic, but these counts had normalized in later childhood, suggesting the lymophenia in this cohort was transient. Similarly, Assing et al. (2013) reported a child with CHARGE who was lymphopenic at birth but had a normal lymphocyte count by 6 months of age. Thus lymphopenia in CHARGE syndrome appears to be more common in early infancy, and may normalise over time. Persistent lymphopenia is always of concern in any infant with CHARGE due to the possibility of complete Di George anomaly. reported 5 out of 24 children had mild-moderately reduced CD3 counts (another three patients had normal CD3 counts, but reduced naïve CD4/CD8 counts indicating probable thymic hypoplasia). Despite the mild-moderate reduced T-cell numbers, the cells appeared to function normally, with normal lymphocyte mitogen proliferation responses and appropriate cytokine secretary function. Nineteen out of 23 children (83%) were reported to have a suboptimal serological response following tetanus, diphtheria and/or H.influenza B vaccination. However, it is important to note that (i) antibody levels were not measured in healthy children to determine the rate of suboptimal response in this group; (ii) no booster was administered to determine if responses remained inadequate; (iii) no child had a poor response to all three vaccines (which would be more immunological significant); and (iv) no child had an antibody defect requiring immunoglobulin infusions with all cases having normal IgG and IgM levels and only one child a reduced IgA level (who responded to two of the three vaccines).
| Reduced CD3 T-cells
Children with CHARGE syndrome and partial thymic hypoplasia can present with more significant reductions in T-cell number, not profound enough to result in complete Di George anomaly, but substantial enough to warrant prophylactic antibiotic therapy or rarely immunoglobulin replacement therapy (Assing et al., 2013; Chopra, Baretto, Duddridge, & Browning, 2009; Jyonouchi et al., 2009; Theodoropoulos, 2003) . In all of these cases, although total immunoglobulin levels were normal, assessment of antibody vaccine responses, and thus the B-cell function, 2.5 | Reduced CD8 T-cell reported reduced CD8 T cells in 11 out of 24 patients (46%; in five cases the reduced CD8 count was the sole T-cell aberration) by applying standard laboratory reference ranges (Comans-Bitter et al., 1997) . The same group reported that a higher proportion of children with CHARGE had reduced CD8 T cells when compared to healthy controls (using the same reference ranges for both groups (Comans-Bitter et al., 1997) ). In contrast, Hsu et al. (2016) found that no child had reduced CD8 counts (nor CD4, or NK cell counts) using the same reference ranges as . The differences between the two studies are not explained by differences in age, given the median age of the cohorts were similar.
When Hsu et al. (2016) compared CD8 cells in CHARGE patients to their own age matched healthy controls, they found CD8 counts were lower in the CHARGE group, but this did not reach statistical significance. Overall, further data is required across a broad range of ages in larger cohorts to clarify whether CD8-penia is a common feature of CHARGE syndrome.
| Complete thymic aplasia
Profound T-cell deficiency due to complete thymic aplasia is the most common immunodeficiency reported in CHARGE syndrome (Table 1) , reflecting a reporting bias of more severe cases.. The term complete Di George is used to describe this phenotype, describing infants with a Di George anomaly (characterized by defects of the heart, thyroid and parathyroid glands) who are athymic (Markert et al., 2007) . Complete Di George anomaly can occur in association with CHARGE, 22q11.2 deletion and diabetic embryopathy (Markert et al., 2007) . Infants with complete Di George syndrome can be further subdivided into typical or atypical (also termed Omenn-like syndrome). Both subtypes can occur in CHARGE and the typical phenotype can evolve into the atypical subtype with the expansion of oligoclonal dysregulated T-cells. The atypical phenotype can be clinically differentiated by the presence of erythroderma, hepatosplenomegaly, lymphadenopathy, elevated IgE, and/or peripheral blood eosinophilia. These patients do not have these clinical features immediately after birth but rather evolve into this phenotype with the expansion of dysregulated oligoclonal T cells within the first months of life. Thus, these infants may initially be profoundly lymphopenic with lymphocyte numbers "normalizing" over time (Gennery et al., 2008) .
The thymus and parathyroid develop from the same pharayngeal pouches, and therefore hypocalcaemia is almost always reported in complete Di George anomaly, suggesting a close correlation between lymphopenia (i.e., and thymic aplasia) and hypocalcaemia (i.e., and hypoparathyroidism) ( Table 1) . Jyonouchi et al., 2009 reported combined hypocalcaemia and lymphopaenia in 14 of 18 CHARGE patients. In contrast only one out of nine patients with normal calcium levels was lymphopenic. Markert et al. (2007) reported 44 children with complete Di George syndrome (due to CHARGE, 22q11.2 deletion and diabetic embryopathy), of whom 36 (82%) had hypocalcaemia requiring supplementation. Hsu et al. (2016) reported a positive correlation between ionized calcium levels and total lymphocyte counts in children with 22q11.2 deletion syndrome but not in those with CHARGE syndrome. However, only 30% of this CHARGE cohort had a calcium level performed and 22q11.2 deletion children were more likely to be lymphopenic (60%) compared to children with CHARGE syndrome (30%). We therefore propose that persistent hypocalcaemia in neonates and infants with CHARGE is a risk factor for thymic hypoplasia/aplasia, and an urgent full blood count and T-B, and NK subsets is required to exclude complete Di George. Naïve T-cells are generally detected within 6 months of thymic transplant and by 2 years, most children can cease immunoglobulin infusions (Markert et al., 2007) . However, such specialized therapy is currently only available in two centers in the world (Great Ormond St Hospital, London, United Kingdom and Duke University Hospital, Durham, USA).
Consequently, other centers have had to rely on bone marrow reconstitution (either bone marrow transplant or cord transplants) or infusion of peripherally harvested lymphocytes with the view that sufficient mature post-thymic naïve T-cells would be needed to expand and rescue the immunological defect (Table 1) . However, the outcome of such transplants is less clear; 3/6 cases had graft vs. host disease, 3/6 died post-transplant, and there is always the risk of graft failure (Gennery et al., 2008; Hoover-Fong et al., 2009; Inoue et al., 2010; Janda et al., 2007) .
| Isolated antibody deficiency
Although co-associated antibody defects occur in infants with the complete Di George phenotype, there have been very few cases of isolated antibody defects. Isolated IgA deficiency has been reported (Jyonouchi et al., 2009) , although IgA deficiency is the most common primary immunodeficiency with a prevalence in healthy blood donors ranging from 1:403 to 1:983 (Urbonas et al., 2016) , so reports may reflect chance associations rather than real relationship. N* = Normal IgG due to transplacental transfer of maternal IgG. **At birth the CD3 count was 0/μl but by 3.5 months of age with the development of atypical complete Di George it was 11,368/μl # There were 54 cases of complete Di George (of which 14 were due to CHARGE), and a number cases had been previously published in other papers. 44 cases went on to thymic transplant (but it is unclear how many of these had CHARGE syndrome). The T-cell counts were not provided but all cases included had to have a naïve T cell count <50/μl (which would indicate the presence of complete thymic aplasia) ## There were another 2 children who died (one had hypocalcaemia, the lymphocyte count was not presented, and the cause of death was unclear; the other case had hypocalcaemia reduced T-cell counts and died of sepsis/hepatic abscess at day 13 of life)
IgG subclass deficiency alone has been reported in CHARGE- (Theodoropoulos, 2003) , but this is not considered immunologically significant without an accompanying functional antibody defect. One child with CHARGE and recurrent respiratory/ear infections did have IgG1 subclass deficiency, associated with reduced titers of Hib and pneumococcal antibodies following routine vaccination (Theodoropoulos, 2003) . The child also had low CD3 counts, impaired mitogen stimulation (Theodoropoulos, 2003) , and required prophylactic antibiotics.
There has been a single case report of a girl with presumed CHARGE (no CHD7 mutation analysis) with hyperIgM syndrome (Bahillo et al., 2003) . However, her clinical features would neither satisfy the current definitions used for hyperIgM (http://www.esid.
org) nor CHARGE syndrome (Blake et al., 1998; Verloes, 2005) .
There have been no convincing cases of specific antibody deficiency (SAD) in CHARGE. In almost every case report or series, polysaccharide responses were either based on protein conjugated pneumococcal vaccination (Jyonouchi et al., 2009; or the type of vaccine administered was not mentioned (Jyonouchi et al., 2009) . Hsu et al. (2016) is the only study to date to systematically examine polysacharride vaccine responses, and found no child had SAD. In this cohort, the children were on average older, with no current history of recurrent suppurative infections. Given SAD appears more likely to occur in infants/younger children, and the condition can spontaneously resolve over time, evaluation of polysaccharide responses in a younger cohort of patients in CHARGE syndrome is required to confirm the findings of Hsu et al. (2016) .
2.8 | Comparison of the immune phenotype between CHARGE and 22q11.2 deletion syndrome CHARGE and 22q11.2 deletion syndromes share significant phenotypic similarities, given that both disorders are associated with impaired development of the pharyngeal arch structures, from which thymic stromal cells are derived (Randall et al., 2009) . CHARGE is much less common (estimated incidence 1:10,000-17,000) (Janssen et al., 2012 ) than 22q11.2 deletion syndrome (estimated incidence 1:4000) (McDonald-McGinn & Sullivan, 2011) and notable phenotypic differences exist between the two conditions (Jyonouchi et al., 2009 However, data from 22q11.2 deletion patients was collected retrospectively and was incomplete, and thus subject to selection bias.
In studies examining 22q11.2 deletion syndrome alone, in addition to the rare but well recognized complete Di George presentation (discussed above), lymphopenia due to reduced T cell numbers is a common feature, but the natural age-related decline in peripheral T cells appears to be blunted in these patients (Jawad, McDonald-Mcginn, Zackai, & Sullivan, 2001) . Antibody deficiencies, including isolated low IgM, IgG, and IgA are also reported in 22q11.2 deletion syndrome. The prevalence of such defects was up to 50% in one study (Gennery, 2012) ; however, in a larger cohort of 855 patients, Patel et al. (2012) found that only 6% of patients had hypogammaglobulinemia. Additionally, SAD has been reported in up to 55% of children with 22q11.2 deletion (Gennery et al., 2002) but Hsu et al. (2016) found that no child with CHARGE had SAD. Overall, 22q11.2 deletion syndrome appears more likely to be associated with immunodeficiency than CHARGE syndrome, with its increased likelihood of lymphopenia and prevalence of antibody deficiencies. However, prospective head to head comparison of these two patient cohorts is required to confirm these observations.
| RECOMMENDATIONS FOR IMMUNE SCREENING IN CHARGE
There is no consensus regarding whether all patients with CHARGE syndrome should be screened for immune deficiency upon diagnosis.
Chopra et al., 2009 recommended lymphocyte subset analysis for all patients in their report of 4 children with CHARGE syndrome with moderate to severe T cell deficiency and infection. Jyonouchi et al. (2009) recommended that all children with CHARGE syndrome be evaluated for T cell and humoral immune deficiency. proposed that specialized immunological tests (such as lymphocyte subset analysis and vaccine responses) should be performed in patients with persistent infections requiring prophylactic antibiotics.
Given the small but real risk of complete Di George in CHARGE syndrome, and in light of published data to date, we recommend that a full blood count with a lymphocyte differential and calcium level should be performed in the neonatal period in all patients with CHARGE syndrome.
Complete Di George must also be considered in any infant with persistent lymphopenia (particularly in the presence of hypocalcaemia), but also in infants with signs of an Omenn-like phenotype or those with normal lymphocyte count and presenting with unusual or invasive infections (e.g., CMV, PCP). 
| FUTURE DIRECTIONS AND RECOMMENDATIONS
There remains a paucity of information with respect to the immune function of patients with CHARGE syndrome. 
